Insider trade

Director received an award of 2,380 UTHR derivative securities

Traded Jul 22, 2026 · Filed Jul 24, 2026

United TherapeuticsUTHR

2,380
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jul 22, 2026
Reporting period: Not applicable
Filed with the SEC: Jul 24, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001231427-26-000004
Filed / recorded

Jul 24, 2026, 12:37 AM UTC

Added to OQRO

Oct 6, 2026, 9:34 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

UNITED THERAPEUTICS Corp

Issuer CIK

1082554

Ticker

UTHR

Reporting person

Christopher Patusky

Relationship

Director

Security

Stock Option

Table

Derivative (Table II)

Transaction date

Jul 22, 2026

Transaction code

A

Shares / units

2,380

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

2,380

Ownership form

Direct

Amendment

No

Footnotes from the filing

Annual non-employee director award.
Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.

Around the same time

Martine A RothblattChairperson & CEO

Filed 7w ago

9,500Shares · @ $135.42

Traded Aug 20 · filed 2 days later

Derivative exercise or conversion — not an open-market buy.

More Official record

Martine A Rothblatt (Chairperson & CEO) sold ~$506K of United Therapeutics

Scheduled in advanceFiled 7w ago

Martine A Rothblatt (Chairperson & CEO) sold ~$781K of United Therapeutics

Scheduled in advanceFiled 7w ago